Annotation Detail

Information
Associated Genes
PCSK9
Associated Variants
PCSK9 MUTATION
PCSK9 MUTATION
Associated Disease
Dyslipidemias
Source Database
DisGeNET
Description
Inhibitors of proprotein convertase subtilisin kexin type 9 (PCSK9) represent a new therapeutic category of drugs for the treatment of dyslipidemia and atherosclerotic cardiovascular disease.
Pubmed
25911073
Section of the abstract supporting the evidence
ALL_TEXT_1/3
Number of the section of the abstract supporting the evidence
1
Number of the sentence supporting the evidence
1
Original source reporting the Gene Disease association
BeFree,LHGDN
DisGENET score for the Gene Disease association
0.00598165270743081
Drugs